EI

251.8

-0.32%↓

SAN

81.4

+0.15%↑

SHL.DE

45.95

-0.2%↓

ARGX

550.8

-1.18%↓

PHIA

23.17

+0.87%↑

EI

251.8

-0.32%↓

SAN

81.4

+0.15%↑

SHL.DE

45.95

-0.2%↓

ARGX

550.8

-1.18%↓

PHIA

23.17

+0.87%↑

EI

251.8

-0.32%↓

SAN

81.4

+0.15%↑

SHL.DE

45.95

-0.2%↓

ARGX

550.8

-1.18%↓

PHIA

23.17

+0.87%↑

EI

251.8

-0.32%↓

SAN

81.4

+0.15%↑

SHL.DE

45.95

-0.2%↓

ARGX

550.8

-1.18%↓

PHIA

23.17

+0.87%↑

EI

251.8

-0.32%↓

SAN

81.4

+0.15%↑

SHL.DE

45.95

-0.2%↓

ARGX

550.8

-1.18%↓

PHIA

23.17

+0.87%↑

Search

Orion Oyj (Class B)

Ouvert

66.45 0.3

Résumé

Variation du prix de l'action

24h

Actuel

Min

66.05

Max

66.8

Chiffres clés

By Trading Economics

Revenu

119M

180M

Ventes

62M

417M

P/E

Moyenne du Secteur

26.431

34.393

BPA

0.59

Rendement du dividende

2.33

Marge bénéficiaire

43.289

Employés

3,700

EBITDA

202M

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

2.33%

2.54%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

1.1B

10B

Ouverture précédente

66.15

Clôture précédente

66.45

Orion Oyj (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

11 août 2025, 17:49 UTC

Principaux Mouvements du Marché

180 Life Sciences Stock Jumps on $156 Million Notes Sale

11 août 2025, 17:18 UTC

Principaux Mouvements du Marché

Tiziana Life Sciences Rises After FDA Approves IND for Foralumab Trial

11 août 2025, 16:25 UTC

Résultats

Correction to Constellation Software 2Q Revenue Rises, Profit Shrinks Article on Aug. 8

11 août 2025, 23:50 UTC

Market Talk

Nikkei May Rise as Yen Weakens -- Market Talk

11 août 2025, 23:42 UTC

Market Talk

Global Energy Roundup: Market Talk

11 août 2025, 23:42 UTC

Market Talk

Woodside's Share Price Implies Lofty Oil Price -- Market Talk

11 août 2025, 23:36 UTC

Market Talk

Gold Edges Higher on Likely Technical Recovery -- Market Talk

11 août 2025, 23:32 UTC

Market Talk

Argosy's New Bull Sees Sentiment Toward REITs Improving -- Market Talk

11 août 2025, 23:02 UTC

Market Talk

RBA Set to Lower OCR With New Forecasts in Focus -- Market Talk

11 août 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

11 août 2025, 20:37 UTC

Résultats
Acquisitions, Fusions, Rachats

Bakkt Holdings: Andy Main Will Step Dn as Co-CEO and Director, Effective Aug 11, and Akshay Naheta Will Assume Role of CEO >BKKT

11 août 2025, 20:37 UTC

Résultats
Acquisitions, Fusions, Rachats

Bakkt Holdings 2Q Rev $577.9M >BKKT

11 août 2025, 20:37 UTC

Résultats
Acquisitions, Fusions, Rachats

Bakkt Holdings: In Upcoming Qtr, Will Conduct Comprehensive Review of Cost Structure to Ensure We Are Optimized, Driving Synergies Across Business, and Accelerating Path to Profitability >BKKT

11 août 2025, 20:22 UTC

Résultats

Exodus Movement: Assets 2,058 Units of Bitcoin Valued at $220.5M, 2,729 Units of Ether Valued at $6.8M, $58.1M in Cash and Cash Equivalents, USD Coin, Treasury Bills as of June 30 >EXOD

11 août 2025, 20:22 UTC

Résultats

Exodus Movement: Monthly Active Users 1.5M at End 2Q, Unchanged From 1.5M as of June 30, 2024 >EXOD

11 août 2025, 20:22 UTC

Résultats

Exodus Movement: Processed Volume $1.38B in 2Q Dn 37% From 1Q, Bitcoin, Tether (TRX Network), Tether (ETH Network), USDC, SOL Top Assets Traded in 2Q >EXOD

11 août 2025, 20:22 UTC

Résultats

Exodus Movement: Digital Assets and Liquid Assets $291.2M >EXOD

11 août 2025, 20:22 UTC

Résultats

Exodus Movement 2Q Rev $25.8M >EXOD

11 août 2025, 20:14 UTC

Market Talk

Canada Dollar Faces Near-Term Weakness on Trade Row, September Rate-Cut Chatter -- Market Talk

11 août 2025, 19:12 UTC

Market Talk

Crude-Oil Futures Edge Up in Rangebound Trade -- Market Talk

11 août 2025, 18:56 UTC

Market Talk

U.S. Natural-Gas Futures Fall on Forecast Loss of Late August Heat -- Market Talk

11 août 2025, 18:31 UTC

Market Talk

Mining Halt Could Lift Lithium Prices in Near Term -- Market Talk

11 août 2025, 17:43 UTC

Market Talk

Freeport-McMoRan Can Push Up Prices, Profits With Copper Tariff Protection -- Market Talk

11 août 2025, 17:28 UTC

Market Talk

Crossborder Trade Tensions Accelerate Softness in Canada Rents -- Market Talk

11 août 2025, 17:16 UTC

Market Talk

Commodity Longs Fall to 11-Month Low -- Market Talk

11 août 2025, 16:42 UTC

Acquisitions, Fusions, Rachats

Adobe Stock Gets a Downgrade. 'AI Is Eating Software,' Analyst Says. -- Barrons.com

11 août 2025, 16:27 UTC

Acquisitions, Fusions, Rachats

BBVA Says Sabadell Offer Remains in Effect

11 août 2025, 16:26 UTC

Acquisitions, Fusions, Rachats

BBVA Previously Said It Won't Withdraw Offer to Buy Sabadell

11 août 2025, 16:25 UTC

Acquisitions, Fusions, Rachats

Banco de Sabadell Announced TSB Sale on July 1

11 août 2025, 16:25 UTC

Acquisitions, Fusions, Rachats

Banco de Sabadell Shareholders Approved TSB Unit Sale on Aug 6

Comparaison

Variation de prix

Orion Oyj (Class B) prévision

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Orion Oyj (Class B)

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer. It also offers Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, the company provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells veterinary drugs manufactured by other international companies. It has partnership with Propeller Health to connect the Easyhaler(R) product portfolio; collaboration and option to license agreement with Abilita Therapeutics to develop innovative antibody therapeutics; and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. to commercialize Amneal's generic products. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.